Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Speciality Medicines Ltd (NSE: SPML), ISIN INE0R0M01014 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
SPML last traded at ₹155.00 (-1.21%), with a 52-week range of ₹121.10 to ₹381.20 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 43.43%, FIIs 0.00%, DIIs 0.00%, mutual funds 0.00%.
EquiSense Score (ECS): 64/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.